Skip to main
University-wide Navigation

New Life Breathed into Lung Cancer Study Initiated 15 Years Ago

Doug Andres is exploring the link between RIT1 mutations and lung cancer.

A Lung Cancer Discovery 15 Years in the Making

Fifteen years ago Douglas Andres and his team produced data that showed mutations in an on-off switch called RIT1 are a novel driver for human lung cancer.

Improving Health Disparities Through Nursing Research

Jenna Hatcher is taking preventive health care into the emergency department, “because for many Kentuckians that’s where they find their medical home."

Markey's D'Orazio Receives Funding to Further Skin Cancer Research

John D'Orazio studies hormonal pathways that protect the skin from sun damage and repair DNA.

Study Finds Potential New Drug Target for Lung Cancer

A new metabolomics study suggests targeting a key enzyme may lead to novel drug development for lung cancer.

UK Receives $3.75 Million For Community-Based Rural Cancer Prevention

The grant funds UK Rural Cancer Prevention Center's work on screening and prevention of colorectal cancer.

UK Announces $3.75 Million Grant for Colorectal Cancer Prevention

On July 10, 2014, UK announced a project in Eastern Kentucky to promote a new at-home cancer screening test.

Tracing Lung Cancer in Appalachian Kentucky

Dr. Susanne Arnold is studying potential environmental reasons for high lung cancer rates in Eastern KY.

Markey Cancer Center Receives NCI Designation

In July 2013, Markey Cancer Center joined an elite group of centers with NCI Designation.

Light-Activated Cancer Drugs

Phoebe Glazer is making light-activated, ruthenium-based molecules that will kill only cancerous cells.

Filter News